CHRISTIAN O HENRY
CIK 1263805 · See Remarks · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.79M
Companies
5
Total Filings
201
Lifetime Open-Market Net
-$99.11M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNA | Director | 34,310 | $7.70 | $264.2K | -$219.8K | 3 | 2026-06-15 |
| PACB | See Remarks | 3,581,813 | $1.39 | $4.98M | -$9.45M | 27 | 2026-03-04 |
| WVE | Director | 27,700 | $5.89 | $163.2K | -$1.56M | 12 | 2025-12-10 |
| Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Director | 1,339,641 | $0.01 | $8.4K | -$20.53M | 20 | 2024-06-14 |
| ILMN | EVP & Chief Commercial Officer | 17,531 | $192.98 | $3.38M | -$67.35M | 115 | 2017-01-31 |
Recent Filings · Page 3 of 21
201 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-18 | PACB | Notice (144) | −259,909 | -$488.1K | EDGAR |
| 2024-09-17 | PACB | Sell (S) | −98,907 | -$172.7K | EDGAR |
| 2024-09-16 | PACB | Notice (144) | −98,907 | -$172.7K | EDGAR |
| 2024-08-14 | WVE | Grant (A) | +16,115 | $0 | EDGAR |
| 2024-06-14 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Mixed | +105,263 | $0 | EDGAR |
| 2024-03-06 | PACB | Sell (S) | −14,177 | -$69.1K | EDGAR |
| 2024-03-04 | PACB | Notice (144) | −14,177 | -$69.1K | EDGAR |
| 2024-02-26 | PACB | Grant (A) | +1,605,769 | $0 | EDGAR |
| 2024-02-21 | PACB | Sell (S) | −81,017 | -$481.3K | EDGAR |
| 2024-02-20 | PACB | Notice (144) | −1,979 | -$10.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.